New cholesterol jab shows promise in Mid-Stage trial
NCT ID NCT07421232
Summary
This study tested a new injectable drug called SYH2053 to see if it could safely lower 'bad' cholesterol (LDL-C) in adults with high cholesterol. It involved 156 participants and compared the new injection against a placebo and an existing treatment. The goal was to find a new option for managing cholesterol levels long-term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA AND MIXED HYPERLIPIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliation: Peking University Third Hospital
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.